Following new government guidance, the UK’s National Health Service (NHS) has plans to roll out automated insulin delivery systems.
Last month, the National Institute for Health and Care Excellence (NICE) issued guidance supporting automated insulin delivery for type 1 diabetes. NICE published guidance recommending hybrid closed-loop systems for eligible people with type 1 diabetes in England and Wales. This was well received in the diabetes community, with Insulet applauding the new guidance.
Hybrid closed-loop systems, like the Insulet Omnipod 5, deliver insulin automatically based on calculations from glucose monitors. Medtronic, Tandem Diabetes Care and Beta Bionics also compete with Insulet in the automated insulin delivery space. Medtronic also applauded automated insulin delivery recommendations from NICE in November.
According to the nonprofit Diabetes UK, NICE agreed to a request from the NHS to allow a phased, five-year implementation. This aims to guide the rollout and assist in delivering the technology, providing access to those who most benefit from it first.
Get the full story at our sister site, Drug Delivery Business News.